Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficient strategies for TALEN-mediated genome editing in mammalian cell lines.
Valton J, Cabaniols JP, Galetto R, Delacote F, Duhamel M, Paris S, Blanchard DA, Lebuhotel C, Thomas S, Moriceau S, Demirdjian R, Letort G, Jacquet A, Gariboldi A, Rolland S, Daboussi F, Juillerat A, Bertonati C, Duclert A, Duchateau P. Valton J, et al. Among authors: paris s. Methods. 2014 Sep;69(2):151-70. doi: 10.1016/j.ymeth.2014.06.013. Epub 2014 Jul 15. Methods. 2014. PMID: 25047178
Radiation Therapy Enhanced by NBTXR3 Nanoparticles Overcomes Anti-PD1 Resistance and Evokes Abscopal Effects.
Hu Y, Paris S, Barsoumian H, Abana CO, He K, Wasley M, Younes AI, Masrorpour F, Chen D, Yang L, Dunn JD, Zhang J, Gandhi S, Nguyen QN, Cortez MA, Welsh J. Hu Y, et al. Among authors: paris s. Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3):647-657. doi: 10.1016/j.ijrobp.2021.06.041. Epub 2021 Jul 6. Int J Radiat Oncol Biol Phys. 2021. PMID: 34242713
A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model.
Hu Y, Paris S, Barsoumian H, Abana CO, He K, Sezen D, Wasley M, Masrorpour F, Chen D, Yang L, Dunn JD, Gandhi S, Nguyen QN, Cortez MA, Welsh JW. Hu Y, et al. Among authors: paris s. J Nanobiotechnology. 2021 Dec 11;19(1):416. doi: 10.1186/s12951-021-01163-1. J Nanobiotechnology. 2021. PMID: 34895262 Free PMC article.
Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer.
Hu Y, Paris S, Bertolet G, Barsoumian HB, He K, Sezen D, Chen D, Wasley M, Silva JD, Mitchell JA, Voss TA, Masrorpour F, Leyton CK, Yang L, Leuschner C, Puebla-Osorio N, Gandhi S, Nguyen QN, Cortez MA, Welsh JW. Hu Y, et al. Among authors: paris s. J Nanobiotechnology. 2022 Sep 19;20(1):417. doi: 10.1186/s12951-022-01621-4. J Nanobiotechnology. 2022. PMID: 36123677 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34701407
455 results